The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/792774
CAPABILITIES COMPATIBILITY DEVELOPMENT EXPERTISE RELIABILITY K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M 2017 CMO LEADERSHIP AWARDS WINNERS 58 LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2017 QUALITY Company Profiles DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: drug development & manufacturing services for oral solid dose, liquids, powders, gels & semisolids, with specialization of contained manufacture of potent compounds. Packaging & distribution services for all delivery forms including oral solid dose, liquids & pow- ders, as well as parenteral delivery forms includ- ing ampoules, vials, syringes & injectable devices. "At PCI Pharma Services, our #1 commitment is to provide the industry's leading customer experi- ence. We hold ourselves to the highest standards and focus on demonstrating a true partnership model with our customers, striving to be a seam- less extension of their supply chains. We are very grateful to be recognized for such a prestigious award and further trusted to be the supplier of choice to the leading pharmaceutical and biotech companies around the world." DRUG TYPE: Pharmaceuticals BILL MITCHELL President & CEO CATEGORIES WON: PCI Pharma Services Philadelphia, PA www.pciservices.com Phone: +1 215 613 3600 Contact: Justin Schroeder Email: justin.schroeder@pciservices.com Key locations: Philadelphia, PA, USA; Rockford, IL, USA; Woodstock, IL, USA; Tredegar, UK; Bridgend, UK; Hay-on-Wye, UK DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Pre- Clinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Drug Substance Production SERVICES & CAPABILITIES: controlled substances, generics, non-sterile, ophthalmics, solid dose, topicals "After nearly 20 years, PCI Synthesis has developed a strong sense of where the industry is headed. We recruit great people and continuously train them. We also spend a lot of time delivering what our clients want: 1. Transparency: Communicating so sponsors always know the status of their projects, and with no surprises. 2. Collaboration: Working together keeps projects on a successful trajectory. 3. Expertise: Adding expertise that's complementary to sponsors' in-house capabilities." DRUG TYPE: Pharmaceuticals ED PRICE President CATEGORIES WON: PCI Synthesis Newburyport, MA www.pcisynthesis.com Phone: +1 978 462 5555 Contact: Ed Price Email: ed.price@pcisynthesis.com Key locations: Newburyport, MA; Devens, MA DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: aseptic fill/finish, cartridges, controlled substances, cytotoxic & high potency compounds, injectables, lyophilized prod- ucts, parenterals: small volume, peptides, solid dose, solutions & suspensions, sterile, syringes: pre-filled, highly potent solid oral dose, custom small-molecule API synthesis, small-molecule ste- roid, hormone intermediates, APIs "We're honored to be recognized by pharmaceuti- cal companies big and small. In fact, up to 70 percent of our biopharma partners start out with us as small to mid-sized companies. As a global contract manufacturer embedded within Pfizer, we leverage Pfizer's experience with 600 medi- cines in more than 160 markets on behalf of our biopharmaceutical partners, regardless of their size, while focusing on their individual technical, cultural, and business needs." DRUG TYPE: Pharmaceuticals, Biopharmaceuticals PETER STEVENSON Vice President & General Manager CATEGORIES WON: Pfizer CentreOne New York, NY www.pfizercentreone.com Phone: +1 269 833 2297 Contact: Olivier Roux Email: pfizercentreone@pfizer.com Key locations: Kalamazoo, MI, USA; McPherson, KS, USA; Rocky Mount, NC, USA; Ringaskiddy/ Little Island, Ireland; Newbridge, Ireland; Mel- bourne, Australia INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on- time, reputation, right first time, state-of-the-art, strength of science INDIVIDUAL ATTRIBUTE AWARDS: right first time, state-of-the-art INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on- time, reputation, right first time, state-of-the-art, strength of science